why choose us

Clinical Trials Search

Showing 5,420 of 132,656 result(s)
Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting

Status: COMPLETED

Condition: Using NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Exam

Interventions:

Date: 2024-03-11

Open Pilot Trial of a Mind-Body Sexual Well-Being Intervention for Female GI Cancer Survivors

Status: COMPLETED

Condition: Colorectal Cancer

Interventions: Weekly virtual group meetings with the study interventionist(s) and up to 9 other female cancer survivors over an approximately 6 week period.
Th

Date: 2024-03-11

A Study to Assess the Safety and Pharmacokinetics of a Single Dose of UCB9741 in Healthy Caucasian and Japanese Participants

Status: COMPLETED

Condition: Healthy Participants

Interventions: Pharmaceutical form: Solution Participants will receive UCB9741 during the Treatment Period.

Date: 2024-03-11

Predicting Local and Distant Recurrence in T1 Colorectal Cancer

Status: COMPLETED

Condition: Colorectal Cancer

Interventions: A panel of microRNA and messenger RNA, whose expression level is tested in macro-dissected formalin-fixed and paraffin-embedded (FFPE) samples derived

Date: 2024-03-11

Artificial Intelligence-based Video Analysis to Detect Infantile Spasms

Status: COMPLETED

Condition: Infantile Spasms

Interventions: DEVICE: Spasm Vision - Machine learning software developed to analyze videos and accurately distinguish infantile spasms from visually similar movemen

Date: 2024-03-11

The Impact of Pumpkin Seed Oil Supplementation on Hemodialysis Patients

Status: COMPLETED

Condition: Hemodialysis Patients

Interventions: Ronkin soft gelatin capsules, each containing 1010 mg of pumpkin seed oil (Latin name: Curcurbita pepo), standardized to contain palmitic acid (8-15%)

Date: 2024-03-11

Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)

Status: COMPLETED

Condition: Acute Myeloid Leukaemia

Interventions: Azacitidine 300 mg Film coated tablets

Date: 2024-03-11

An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With Schizophrenia

Status: COMPLETED

Condition: Schizophrenia

Interventions: Administered subcutaneously (sc)

Date: 2024-03-11

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

Status: COMPLETED

Condition: Central Nervous System (CNS) Lesions

Interventions: MRI contrast agent

Date: 2024-03-11

Effect of Telitacicept on Antibody Titers in Primary APS Patients

Status: COMPLETED

Condition: Antiphospholipid Syndrome (APS)

Interventions: 160mg once a week for 48 weeks

Date: 2024-03-11